WEST DES MOINES, IA--(Marketwired - Apr 21, 2015) - Spotlight Innovation Inc. (
Cris Grunewald, President and CEO of Spotlight Innovation, stated, "We are grateful for investors' enthusiastic response to both our progress-to-date and to our strong potential. The financing allows us to continue our identification and support of high-impact intellectual property in the healthcare space, and to ultimately have a positive impact on the health, well-being and quality-of-life of as many people as possible."
About Spotlight Innovation Inc.
Spotlight Innovation Inc. (
Forward Looking Statements
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.
Contact Information:
Press Contact
Rene Erickson
Spotlight Innovation Inc.
1-515-274-9087
corpcomm@spotlightinnovation.com
Investor Relations Contact
Mike Reysack
Spotlight Innovation Inc.
1-641-512-1035
investor.relations@spotlightinnovation.com